Fundz

Viatris Closes Acquisitions Of Oyster Point Pharma And Famy Life Sciences, Establishing New Viatris Eye Care Division

PUBLIC · VTRSJan 03, 2023

Acquiring Company

Viatris

Acquired Company

Famy Life Sciences

CanonsburgSan FranciscoHealthcare

Description

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris' strategic update. Former Oyster Point Pharma CEO, Jeffrey Nau, Ph.D., MMS, will lead the new division.

Quick answer

Viatris is acquiring Famy Life Sciences and Oyster Point Pharma, Inc., announced January 3, 2023. Viatris is based in Canonsburg, Pennsylvania, United States.

How much did Viatris pay for Famy Life Sciences?
The deal value was not disclosed.
What does Viatris do?
Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania.
Where are Viatris and Famy Life Sciences based?
Viatris is based in Canonsburg, Pennsylvania, United States.

Source: Fundz verified event record.

Other recent acquisitions in Healthcare

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Viatris, and when

When Viatris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Viatris raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viatris, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viatris. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viatris

Location

Canonsburg, Pennsylvania, United States

About

Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Formed in November 2020 from the merger of Mylan and Pfizer's Upjohn division, Viatris aims to enhance access to medicines worldwide. The company operates in over 165 countries and territories, delivering high-quality medicines to patients. Viatris offers a diverse portfolio that includes generics, established brands, biosimilars, and innovative specialty medicines. Their product range encompasses oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients. The company addresses various therapeutic areas, such as cardiovascular health, oncology, infectious diseases, and women's healthcare. In addition to its products, Viatris provides support services like diagnostic clinics and educational seminars to help patients manage their health effectively. With a workforce of around 45,000 employees, Viatris serves a wide array of customers, including hospitals, clinics, and pharmacies, across multiple market segments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Viatris's next move

Learn about Strategic plan

Frequently asked

Who acquired Famy Life Sciences?

Famy Life Sciences was acquired by Viatris, based in Canonsburg. The deal was reported on January 3, 2023. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).

When did Viatris acquire Famy Life Sciences?

Viatris's acquisition of Famy Life Sciences was reported on January 3, 2023. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Famy Life Sciences do?

Famy Life Sciences is a well-known drug development platform specializing in identifying and in-licensing best-in-class clinical-stage assets. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.